PTGER1 and lung carcinoma: The usefulness of treatment strategies by antagonists of each EP receptor has been reported in various types of malignancies; for example, the EP1 and EP2 receptors for breast cancer46,47, EP3 receptor for oral cancer48, and EP4 receptor for lung cancer and breast cancer43,49,50.